rapid
accur
diagnosi
viral
respiratori
infect
crucial
patient
manag
multiplex
revers
transcriptas
polymeras
chain
reaction
mrtpcr
use
increasingli
diagnos
respiratori
infect
shown
sensit
viral
cultur
antigen
detect
object
present
studi
develop
onestep
mrtpcr
could
detect
respiratori
virus
three
set
method
compar
real
time
rtpcr
rrtpcr
sensit
specif
clinic
specimen
pediatr
patient
respiratori
symptom
use
studi
sampl
detect
posit
mrtpcr
exhibit
presenc
singl
pathogen
multipl
pathogen
rrtpcr
detect
posit
sampl
exhibit
one
viru
show
coinfect
concord
mrtpcr
rrtpcr
kappa
correl
sensit
specif
mrtpcr
rrtpcr
respect
rhinoviru
frequent
detect
viru
follow
respiratori
syncyti
viru
b
parainfluenza
metapneumoviru
conclus
mrtpcr
rapid
cost
effect
specif
highli
sensit
method
detect
respiratori
virus
respiratori
viral
diseas
seriou
public
health
problem
global
social
econom
impact
respiratori
virus
caus
diseas
rang
mild
respiratori
ill
fatal
pneumonia
contribut
significantli
morbid
mortal
worldwid
william
et
al
clinic
present
respiratori
viral
infect
similar
etiolog
diagnosi
base
clinic
paramet
difficult
rapid
diagnosi
essenti
prompt
patient
manag
public
health
action
diagnosi
viral
respiratori
infect
base
use
convent
method
isol
cell
cultur
antigen
detect
although
method
effect
often
complementari
certain
limit
cell
cultur
consid
gold
standard
viru
detect
labori
time
consum
antigen
detect
insuffici
sensit
andor
specif
sensit
specif
respiratori
viru
detect
improv
consider
advent
nucleic
acid
amplif
test
nat
bellaupujol
et
al
fox
freymuth
et
al
liolio
et
al
vabret
et
al
weinberg
et
al
enabl
rapid
respons
potenti
outbreak
desir
fast
accur
comprehens
diagnost
method
capabl
detect
simultan
subtyp
virus
howev
expens
use
viru
specif
pcr
assay
sever
group
develop
multiplex
rtpcr
identifi
respiratori
virus
clinic
sampl
bellaupujol
et
al
bharaj
et
al
brittainlong
et
al
coira
et
al
gunson
et
al
jansen
et
al
kim
et
al
lee
et
al
mahoni
et
al
pabbaraju
et
al
wang
et
al
prefer
one
test
depend
specif
sensit
turnaround
time
well
cost
resourc
limit
set
purpos
studi
develop
one
step
mrtpcr
could
detect
respiratori
virus
includ
influenza
virus
season
influenza
b
virus
respiratori
syncyti
viru
rsv
b
human
metapneumoviru
hmpv
parainfluenza
virus
piv
rhinoviru
enteroviru
corona
virus
three
set
human
clinic
sampl
compar
rrtpcr
primer
use
assay
design
use
dual
prime
oligonucleotid
dpo
technolog
allow
specif
detect
virus
without
non
specif
amplif
chun
et
al
conserv
region
target
gene
chosen
design
forward
revers
primer
mrtpcr
differ
viral
gene
pcr
product
size
given
tabl
primer
sequenc
provid
request
mrtpcr
primer
obtain
sigma
bangalor
india
multiplex
rt
pcr
carri
tube
set
set
influenza
subtyp
season
pandem
influenza
b
set
rsva
rsvb
hmpv
set
corona
viru
corona
viru
rhinovirusenteroviru
mrtpcr
differenti
corona
viru
rhinoviru
enteroviru
monoplex
one
step
real
time
rt
pcr
rrtpcr
influenza
subtyp
season
pandem
influenza
b
intern
control
rnasep
carri
per
protocol
provid
center
diseas
control
prevent
usa
cdc
cdc
protocol
rsva
b
corona
viru
rhinoviru
rrtpcr
assay
perform
describ
gunson
et
al
hmpv
maertzdorf
et
al
describ
follow
websit
rrtpcr
influenza
rsva
rhinoviru
coronaviru
taqman
probe
label
fam
fluorescein
amidit
rsvb
coronaviru
label
vic
real
time
pcr
primer
taqman
probe
obtain
appli
biosystem
usa
tissu
cultur
grown
virus
use
posit
control
influenza
b
season
influenza
rsva
b
hmpv
enteroviru
clinic
sampl
posit
rhinoviru
human
corona
viru
confirm
sequenc
use
check
primer
cross
reactiv
nasal
nasopharyng
throat
swab
specimen
ili
influenza
like
ill
sari
sever
acut
respiratori
ill
patient
collect
juli
august
refer
nation
institut
virolog
differ
hospit
pune
diagnosi
use
studi
studi
approv
institut
ethic
committe
total
clinic
specimen
pediatr
patient
test
convent
mrtpcr
monoplex
rrtpcr
one
hundr
fourteen
influenza
posit
sampl
season
season
influenza
b
use
valid
multiplex
assay
set
rna
extract
use
magmax
autom
rna
extractor
per
manufactur
instruct
fifti
microlitr
clinic
sampl
use
rna
extract
final
elut
l
elut
buffer
amplif
convent
mrtpcr
carri
geneamp
pcr
system
use
invitrogen
superscript
iii
one
step
rtpcr
kit
master
mix
mrtpcr
compris
l
buffer
l
enzym
mix
forward
revers
primer
l
rna
templat
make
l
reaction
neg
posit
control
run
experi
thermal
cycl
condit
c
min
revers
transcript
initi
denatur
c
min
cycl
three
step
c
c
c
final
extens
c
min
l
pcr
product
mix
gel
load
dye
run
agaros
gel
contain
ethidium
bromid
visual
uv
transillumin
real
time
rtpcr
assay
perform
appli
biosystem
abi
machin
use
invitrogen
superscript
iii
one
step
qrtpcr
kit
typic
l
pcr
reaction
compris
forward
revers
primer
taqman
probe
l
buffer
l
superscript
iii
enzym
l
rna
templat
thermal
cycl
condit
rrtpcr
c
min
revers
transcript
initi
denatur
c
min
cycl
c
c
specif
multiplex
pcr
assay
evalu
cross
reaction
test
known
viral
isol
differ
panel
sequenc
confirm
known
clinic
respiratori
sampl
refer
materi
assay
set
also
test
influenza
newcastl
diseas
viru
procur
nation
institut
virolog
viru
repositori
world
health
organ
influenza
panel
qaqc
analyz
sensit
known
posit
sampl
subject
monoplex
pcr
forward
primer
tag
promot
gel
electrophoresi
agaros
gel
band
expect
size
observ
band
extract
agaros
gel
use
qiagen
gel
extract
kit
qiagen
germani
purifi
pcr
product
quantifi
use
nanoplex
nanophotomet
implant
germani
vitro
transcript
carri
use
ribomax
vitro
transcript
system
promega
per
manufactur
instruct
promega
usa
rna
purifi
use
qiagen
rna
extract
kit
estim
use
nanoplex
nanophotomet
rna
copi
number
calcul
fold
serial
dilut
vitro
rna
perform
copi
number
refer
number
copi
target
gene
use
ascertain
limit
detect
assay
concentr
test
target
set
copi
set
copi
copi
templat
rna
per
reaction
limit
detect
lod
defin
lowest
concentr
target
could
detect
consist
pcr
product
detect
gel
electrophoresi
posit
control
prepar
pool
vitro
rna
set
initi
pcr
set
use
monoplex
primer
relev
target
gene
mastermix
composit
thermal
cycl
condit
describ
mrtpcr
pcr
product
purifi
use
qiagen
pcr
purif
kit
accord
manufactur
instruct
purifi
product
use
set
cycl
sequenc
reaction
sequenc
primer
follow
mastermix
sequenc
buffer
l
cycl
sequenc
reaction
mix
l
primer
l
ddw
l
templat
l
thermal
cycl
condit
c
min
cycl
c
c
c
min
cycl
sequenc
product
purifi
use
qiagen
dyeex
cycl
sequenc
purif
kit
per
manufactur
instruct
appli
biosystem
capillari
sequenc
use
sequenc
result
analyz
use
sequenc
analysi
softwar
sequenc
confirm
use
ncbi
blast
statist
analysi
carri
use
pasw
statist
softwar
agreement
two
diagnost
test
calcul
mean
concord
kappa
statist
sensit
specif
one
test
refer
vice
versa
also
comput
specif
mrtpcr
assay
evalu
cross
reaction
test
known
respiratori
viru
isolatesposit
sampl
qaqc
panel
influenza
virus
show
cross
reactiv
amongst
differ
virus
product
expect
size
obtain
viral
target
presenc
primer
respect
multiplex
pcr
specif
product
could
distinguish
agaros
gel
electrophoresi
base
size
confirm
observ
band
sequenc
amplifi
pcr
product
carri
valid
set
multiplex
assay
respiratori
clinic
specimen
previous
posit
influenza
virus
rrtpcr
use
result
concord
coinfect
observ
one
sampl
season
influenza
detect
confirm
sequenc
hemagglutinin
ha
neuraminidas
na
gene
set
mrtpcr
detect
specif
season
influenzaa
virus
detect
univers
influenzaa
product
bp
influenza
panel
sampl
exhibit
band
correspond
influenzaa
sampl
confirm
influenza
sequenc
matrix
gene
analyt
sensit
convent
multiplex
assay
determin
test
fold
serial
dilut
quantifi
rna
transcript
target
set
detect
rna
copi
per
reaction
target
set
detect
rsva
copi
per
reaction
hmpv
copi
per
reaction
rsvb
rna
copi
per
reaction
set
detect
enteroviru
copi
per
reaction
rhinoviru
corona
rna
copi
per
reaction
mrtpcr
experi
repeat
three
time
use
three
set
obtain
consist
limit
detect
viru
mrtpcr
tabl
supplementari
data
associ
articl
found
onlin
version
http
overal
concord
method
kappa
correl
sensit
specif
mrtpcr
respect
consid
rrtpcr
gold
standard
convers
sensit
specif
rrtpcr
respect
consid
mrtpcr
gold
standard
tabl
season
influenza
b
rsva
b
concord
observ
use
method
sensit
specif
rhinoviru
use
mrtpcr
rrtpcr
respect
thirti
seven
sampl
posit
rhinovirusenteroviru
mrtpcr
neg
rrtpcr
select
randomli
sequenc
utr
region
sequenc
result
confirm
sampl
rhinoviru
enteroviru
hmpv
sensit
specif
mrtpcr
sensit
specif
respect
rrtpcr
sampl
posit
mrtpcr
neg
rrtpcr
confirm
posit
hmpv
sequenc
sensit
specif
mrtpcr
rrtpcr
respect
among
posit
clinic
sampl
approxim
sampl
show
amplif
band
correspond
test
use
monoplex
primer
neg
indic
band
nonspecif
sensit
specif
rrtpcr
respect
four
sampl
neg
rrtpcr
sequenc
found
randomli
select
corona
viru
posit
sampl
sequenc
confirm
corona
viru
rhinoviru
respiratori
viru
detect
frequent
follow
rsvb
sampl
sampl
hmpv
sampl
corona
viru
detect
sampl
rrtpcr
shown
supplementari
tabl
rhinoviru
detect
frequent
coinfect
follow
rsv
coinfect
confirm
perform
monoplex
pcr
respect
primer
major
respiratori
viral
pathogen
record
global
rsv
influenza
viru
metapneumoviru
parainfluenza
viru
rhinoviru
enteroviru
adenoviru
bocaviru
number
studi
attempt
develop
evalu
multiplex
pcr
detect
variou
respiratori
virus
auburn
et
al
bellaupujol
et
al
boonsuk
et
al
brittainlong
et
al
coira
et
al
jansen
et
al
kim
et
al
mahoni
et
al
suwannakarn
et
al
wang
et
al
first
studi
use
singl
step
mrtpcr
detect
respiratori
virus
clinic
specimen
convent
mrtpcr
conserv
region
gene
select
tabl
set
assay
produc
distinct
size
pcr
product
could
visual
easili
differenti
agaros
gel
electrophoresi
limit
multiplex
pcr
lack
intern
control
check
qualiti
sampl
mrtpcr
sensit
determin
test
fold
serial
dilut
quantifi
rna
transcript
target
multiplex
pcr
set
detect
rna
copiesreact
target
compar
multiplex
pcr
develop
kim
et
al
influenza
type
kit
avail
commerci
seeplex
ab
type
kit
sensit
specif
detect
compar
cdc
real
time
rtpcr
choi
et
al
sensit
specif
mrtpcr
show
excel
concord
cdc
real
time
rtpcr
multiplex
rtpcr
detect
sampl
posit
one
respiratori
virus
list
real
time
pcr
detect
sampl
posit
supplementari
tabl
low
detect
rate
rrtpcr
mainli
due
low
sensit
detect
rhinoviru
metapneumoviru
previous
detect
rate
report
brittainlong
et
al
broor
et
al
coira
et
al
kim
et
al
mahoni
et
al
maitreyi
et
al
yeolekar
et
al
coinfect
describ
previous
approxim
infect
patient
differ
studi
brittainlong
et
al
coira
et
al
kim
et
al
mahoni
et
al
wang
et
al
one
biggest
advantag
mrtpcr
abil
detect
coinfect
often
undetect
viral
cultur
immunofluoresc
detect
sever
case
coinfect
detect
use
pcr
method
multiplex
rtpcr
detect
sampl
coinfect
includ
sampl
virus
detect
wherea
rrtpcr
detect
sampl
coinfect
one
case
coinfect
influenza
virus
also
detect
coinfect
differ
influenza
virus
occur
natur
play
import
role
evolut
epidemiolog
pathogen
viru
concord
method
season
influenza
b
rsva
b
lower
detect
rate
rrtpcr
due
lower
sensit
system
rhinoviru
hmpv
may
due
sequenc
variat
primer
probe
bind
region
indian
subtyp
frequenc
coronaviru
low
larger
number
sampl
requir
better
assess
clinic
sensit
specif
multiplex
rtpcr
score
monoplex
rrtpcr
resourc
limit
set
cost
mrtpcr
virus
discuss
approxim
us
wherea
real
time
pcr
us
moreov
real
time
pcr
machin
expens
compar
convent
thermal
cycler
one
step
multiplex
rtpcr
assay
develop
present
studi
provid
simpl
rapid
cost
effect
method
detect
differ
respiratori
virus
human
clinic
specimen
mrtpcr
sensit
specif
rrtpcr
base
assay
mrtpcr
assay
use
respiratori
viru
surveil
well
diagnosi
